Application of Mahalanobis-Taguchi System in Liver Function Profile of Methadone Flexi Dispensing Program-Reference-Cited by-同舟云学术

Application of Mahalanobis-Taguchi System in Liver Function Profile of Methadone Flexi Dispensing Program

Published:2022-10-31 Issue:2 Volume:9 Page:1158-1176
ISSN:2289-7771
Container-title:Journal of Applied Science & Process Engineering
language:
Short-container-title:J. Appl. Sci. Process Eng.

Author:

Zaini S N A M,Saad S K M,Abu M Y

Abstract

Patients under the methadone flexi dispensing (MFlex) program are required to do blood tests like liver function profile. A doctor assesses 3 parameters like Alk phosphatase, ALT (SGPT), and AST (SGOT) to ensure the patient has a liver problem. Consequently, the existing system does not have a stable ecosystem towards classification and optimization. The objective is to apply the Mahalanobis-Taguchi system (MTS) in the MFlex program. The data is collected at Bandar Pekan clinic with 34 parameters. Two types of MTS methods are used like RT-Method and T-Method for classification and optimization respectively. The average Mahalanobis distance (MD) of healthy is 1.00 and unhealthy is 352.58. A positive degree of contribution has only 1 parameter. 15 unknown samples have been diagnosed. Type 2 of 6 modifications has been selected as the best-proposed solution. In conclusion, a pharmacist from Bandar Pekan clinic confirmed that MTS can solve problems in the classification and optimization of MFlex program.

Publisher

UNIMAS Publisher

Subject

Industrial and Manufacturing Engineering,General Business, Management and Accounting,Materials Science (miscellaneous),Business and International Management

Reference22 articles.

1. [1] Waly, G. (2021). World Drug Report 2021. United Nations: Office on Drugs and Crime. http://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html

2. [2] Buntat, Y., & Rahaman, D. R. (2014). Addiction profile among addicts detained at CRCC throughout Malaysia. Jurnal Antidadah Malaysia, 12(1), 110-121. ISSN: 1985-1707

3. [3] Yuswan, F., & Dazali, M. N. M. (2016). Policies and Standard Operating Procedures Methadone Treatment Program. 7-42.

4. [4] Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., & Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113(10), 1905-1926. https://doi.org/10.1111/add.14234

5. [5] Ministry of Health of Malaysia. (2019). Malaysia Country Report on Drug Issues 2019. Alternative Development towards a Drug-Free ASEAN Community, 1-27.